Cardinal Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
11.6%projected annual EPS growth
Analyst Coverage
15analysts covering
FY Revenue (est.)
$265.5Bnext fiscal year
FY EPS (est.)
$10.23next fiscal year
Monitoring Framework
Key Performance Indicators
Pharmaceutical and Specialty Solutions Segment Profit Growth AnnuallyTarget: 5% to 7% normalized growth
Other Segment Profit Growth AnnuallyTarget: ~10% normalized growth
Total Adjusted Free Cash Flow (3-Year Cumulative) AnnuallyTarget: At least $10 billion over FY26-FY28
Baseline Share Repurchases AnnuallyTarget: At least $750 million per year
Watch Items
- GLP-1 Distribution Volume and Revenue ModerationTrigger: Significant deceleration in GLP-1 product demand or margin compressionAction: Re-evaluate top-line growth forecasts and adjust inventory management strategies
- DOJ Anti-Kickback Statute InvestigationTrigger: Formal charges, material settlement announcements, or legal penaltiesAction: Assess financial impact on cash flows and potential reputational damage to the specialty business
- Global Medical Products and Distribution (GMPD) Tariff ExposureTrigger: Implementation of new or increased tariffs on medical suppliesAction: Review pricing structures and supply chain sourcing to mitigate margin erosion
Research as of 2 Sep 2026